Recruiting ADHD Studies in Pittsburgh
AWARE: Management of ADHD in Autism Spectrum Disorder
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents wit...
Evaluating Treatment of ADHD in Children with Down Syndrome
Children with Down syndrome (DS) have a 3-5 time greater prevalence of Attention Deficit Hyperactivity Disorder (ADHD) than typically developing (TD) children. Despite this higher risk of ADHD, rates ...
About ADHD Clinical Trials in Pittsburgh
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.
There are currently 2 adhd clinical trials recruiting participants in Pittsburgh, PENNSYLVANIA. These studies are seeking a combined 600 participants. Research is being sponsored by Daniel Coury, Children's Hospital Medical Center, Cincinnati. Clinical trial participation is free and participants receive study-related medical care at no cost.
ADHD Clinical Trials in Pittsburgh — FAQ
Are there adhd clinical trials in Pittsburgh?
Yes, there are 2 adhd clinical trials currently recruiting in Pittsburgh, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Pittsburgh?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.
Are clinical trials in Pittsburgh free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.
What adhd treatments are being tested?
The 2 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.
Data updated March 2, 2026 from ClinicalTrials.gov